InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Discover the detailed record of transactions filed by Bailey Jeffrey Allen, 董事长兼首席执行官. Director active across 2 companies, notably Biodelivery Sciences International INC. In total, 7 reports have been recorded. History available since 6 August 2021. The latest transaction was filed on 21 November 2025 (Retenue fiscale). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 条申报中的 7 条
Bailey Jeffrey Allen is President and Chief Executive Officer. He is associated with Biodelivery Sciences International INC, where he is Chief Executive Officer, and with Aurinia Pharmaceuticals Inc., where he is Director. The record shows 7 filings in total, with sampled filings from 2021-08-10 to 2025-11-24; the most common transaction nature is option exercise, and the cumulative buy and sell amounts in this sample are 0 and 0.